BB
Beta Bionics, Inc.
BBNX · NASDAQ
$21.89 +2.39% (+$0.51)
1M +14.91%
Market Cap $964.1M
P/E Ratio -
Div. Yield -
ROE 26.30%
Piotroski F-Score Weak
2/9Valuation
29 /100
Expensive P/B 3.76x
P/S 8.10x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 180.73%
Rev. growth 724.29%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 69.75%
Gross margin 58.31%
FCF margin 51.60%
Quality
5 /100
Poor ROA 24.96%
ROIC 30.98%
Asset turnover 0.41x
Debt
100 /100
Low Current ratio 8.88x
Debt/Equity 0.03x
Debt/Assets N/A
Stability
15 /100
Unstable EPS volatility 41.24%
Beta 3.36x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BBNX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sean T. Saint
Employees
422
Headquarters
Irvine
Evenimente viitoare
27 OCT.
Earnings
Upcoming earnings report